GLP-1 Drugs Linked to Lower Rates of Substance Use Disorders
The study adds to a growing body of evidence indicating that GLP-1 medications may have an influence on dopamine signaling and other neural pathways that drive...
The study adds to a growing body of evidence indicating that GLP-1 medications may have an influence on dopamine signaling and other neural pathways that drive cravings not just for food but other substances. The post GLP-1 Drugs Linked to Lower Rates of Substance Use Disorders appeared first on Inside Precision Medicine .